Evidence map›Paper›PMID 40431242›Full record

ArticleMicroorganisms2025

First Report of Genetic Resistance to Azithromycin in

Dayana Nicté Vergara-Ortega, Perla J Santibañez-Amador, Santa García-Cisneros, María Olamendi-Portugal, Everardo Gutiérrez-Millán, Antonia Herrera-Ortíz, Verónica Ruíz-González, Miguel Ángel Sánchez-Alemán

Abstract read
In one paragraph

Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dayana Nicté Vergara-OrtegaCentro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca CP 62100, Mexico.ORCID 0000-0002-3111-0099
Perla J Santibañez-AmadorCentro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca CP 62100, Mexico.ORCID 0009-0005-0571-9799
Santa García-CisnerosCentro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca CP 62100, Mexico.
María Olamendi-PortugalCentro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca CP 62100, Mexico.ORCID 0000-0002-5227-7541
Everardo Gutiérrez-MillánCentro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca CP 62100, Mexico.
Antonia Herrera-OrtízCentro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca CP 62100, Mexico.ORCID 0000-0001-6307-0370
Verónica Ruíz-GonzálezLaboratorio Especializado, Clínica Especializada Condesa, Cuauhtémoc CP 06170, Mexico.
Miguel Ángel Sánchez-AlemánCentro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca CP 62100, Mexico.ORCID 0000-0003-2383-7930

Funding

Consejo Nacional de Humanidades, Ciencias y Tecnologías 320696
6 · The paper itself

Abstract

Syphilis is a re-emerging sexually transmitted disease caused by

Indexed as

azithromycindrug resistancemacrolidesmen who have sex with menpeople living with HIVsyphilis

Identifiers

PMID40431242
PMCPMC12114566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.